Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Donald

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Plos One|January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United StatesNaglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
The Journal of Biological Chemistry|February 9, 2002
Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic targetAnne M Gurnett, Paul A Liberator, Paula M Dulski, et al.
Scientific Reports|March 7, 2025
Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in South African infantsCourtney P Olwagen, Alane Izu, Shama Khan, et al.
Plos Pathogens|February 19, 2025
Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccineNatalie C Silmon de Monerri, Ye Che, Joshua A Lees, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Plos One|April 15, 2025
Assessment of community knowledge on non-communicable diseases to inform the pilot of WHO PEN-Plus initiatives in selected two districts in TanzaniaGibson B Kagaruki, Peter Mathias Karoli, Willfredius M Rutahoile, et al.
Infection and Immunity|March 21, 2022
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli InfectionsLaurent Chorro, Zhenghui Li, Ling Chu, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compoundsS D Guile, J R Bantick, D R Cheshire, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Plos One|January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United StatesNaglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
The Journal of Biological Chemistry|February 9, 2002
Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic targetAnne M Gurnett, Paul A Liberator, Paula M Dulski, et al.
Scientific Reports|March 7, 2025
Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in South African infantsCourtney P Olwagen, Alane Izu, Shama Khan, et al.
Plos Pathogens|February 19, 2025
Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccineNatalie C Silmon de Monerri, Ye Che, Joshua A Lees, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Plos One|April 15, 2025
Assessment of community knowledge on non-communicable diseases to inform the pilot of WHO PEN-Plus initiatives in selected two districts in TanzaniaGibson B Kagaruki, Peter Mathias Karoli, Willfredius M Rutahoile, et al.
Infection and Immunity|March 21, 2022
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli InfectionsLaurent Chorro, Zhenghui Li, Ling Chu, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compoundsS D Guile, J R Bantick, D R Cheshire, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Pageof 15